Abstract
Accurate determination of plasma renin activity (PRA) is essential for the development and maintenance of an effective screening program for primary aldosteronism (PA). PRA measurement can also be useful in the investigation of renal artery stenosis, syndrome of mineralocorticoid excess, Addison’s disease, congenital adrenal hyperplasia, Bartter and Gitelman syndromes, and for inherited defects in the renin angiotensin aldosterone system (RAAS). We describe a semi-automated and simple method for the accurate and precise measurement of PRA from 500 μL of plasma (250 μL if blank subtraction is omitted, as discussed) using a liquid chromatography and tandem mass spectrometry (LC-MS/MS) method for angiotensin I (AngI) in 96-well format. After a 3 h AngI generation step at 37 °C in buffering conditions at pH 6, the reaction is quenched with 10 % formic acid containing AngI internal standard. Sample preparation then proceeds with offline solid phase extraction, two wash steps, and methanol elution followed by injection into the LC-MS/MS system. Quantitation is performed against a 7-point calibration linear curve prepared in buffer. The assay calibration range is 0.34–30.0 ng/mL which corresponds to PRA values of 0.11–10.0 ng/mL/h: much wider than was possible using traditional competitive antibody-based methods. Total precision in clinical production has been observed to be 5.8 to 5.0 % for Bio-Rad Hypertension Control materials having nominal PRA values ranging from 1.73 to 12.43 ng/mL/h. At AngI concentrations of 0.06 ng/L (corresponding to a PRA of 0.02 ng/mL/h), signal to noise ratios are 50:1 indicating that the limit of quantitation is well below the level required for clinical use.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Young WF (2007) Primary aldosteronism: renaissance of a syndrome. Clin Endocrinol (Oxf) 66:607–618
Funder JW, Carey RM, Fardella C et al (2008) Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 93:3266–3328
Young WF (1997) Primary aldosteronism: update on diagnosis and treatment. Endocrinologist 7:213–221
Campbell DJ, Nussberger J, Stowasser M et al (2009) Activity assays and immunoassays for plasma renin and prorenin: information provided and precautions necessary for accurate measurement. Clin Chem 55:867–877
Sealey JE, Laragh JH (1975) Radioimmunoassay of plasma renin activity. Semin Nucl Med 5:189–202
Fredline VF, Kovacs EM, Taylor PJ et al (1999) Measurement of plasma renin activity with use of HPLC-electrospray-tandem mass spectrometry. Clin Chem 45:659–664
Bystrom CE, Salameh W, Reitz R et al (2010) Plasma renin activity by LC-MS/MS: development of a prototypical clinical assay reveals a subpopulation of human plasma samples with substantial peptidase activity. Clin Chem 56:1561–1569
Carter S, Owen LJ, Kerstens MN et al (2012) A liquid chromatography tandem mass spectrometry assay for plasma renin activity using online solid-phase extraction. Ann Clin Biochem 49:570–579
Owen LJ, Adaway J, Morris K et al (2014) A widely applicable plasma renin activity assay by LC-MS/MS with offline solid phase extraction. Ann Clin Biochem 51:409–411
Popp R, Malmström D, Chambers AG et al (2014) An automated assay for the clinical measurement of plasma renin activity by immuno-MALDI (iMALDI). Biochim Biophys Acta 1854:547–558
Sealey JE, Gordon RD, Mantero F (2005) Plasma renin and aldosterone measurements in low renin hypertensive states. Trends Endocrinol Metab 16:86–91
Clarke W, Molinaro RJ, Bachmann LM et al (2014) C62-A: liquid chromatography-tandem mass spectrometry methods; approved guideline. Clinical and Laboratory Standards Institute. 34:1–71
Salit ML, Ciesiolka T, Greenberg N et al (2006) EP-32-R: metrological traceability and its implementation; a report. Clinical and Laboratory Standards Institute. 26:1–43
Rehan M, Raizman JE, Cavalier E et al (2015) Laboratory challenges in primary aldosteronism screening and diagnosis. Clin Biochem 48:377–387
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer Science+Business Media New York
About this protocol
Cite this protocol
Van Der Gugten, J.G., Holmes, D.T. (2016). Quantitation of Plasma Renin Activity in Plasma Using Liquid Chromatography–Tandem Mass Spectrometry (LC-MS/MS). In: Garg, U. (eds) Clinical Applications of Mass Spectrometry in Biomolecular Analysis. Methods in Molecular Biology, vol 1378. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-3182-8_26
Download citation
DOI: https://doi.org/10.1007/978-1-4939-3182-8_26
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-3181-1
Online ISBN: 978-1-4939-3182-8
eBook Packages: Springer Protocols